Platinum Management
Platinum fires back at Echo Therapeutics over ‘rogue’ directors
Echo Therapeutics hits back at Platinum Equity
Proxy war rages on at Echo Therapeutics
Echo Therapeutics‘ (NSDQ:ECTE) suspension of operations hasn’t stopped a pair of recently appointed renegade board members from using their perch to agitate for change.
Johnson & Johnson plans to file for approval 30 “major” products | Medtech Wall Street news for the week of May 26, 2014
Zimmer looks to avoid layoffs in Biomet merger | Medtech personnel moves for the week of May 26, 2014
Echo Therapeutics proxy war gets ugly amid alleged threats
Embattled Echo Therapeutics (NSDQ:ECTE) issued a new volley against its proxy war rival and largest shareholder Platinum Group, accusing the activist investor of conspiring to tank the company’s stock.